Kaposi Sarcoma
📧 Sign up to get email alerts when something new happens for Kaposi Sarcoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-04-24EMA Authorised: Caelyx pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.
EMA authorised Caelyx pegylated liposomal doxorubicin hydrochloride for Kaposi's sarcoma, multiple myeloma, ovarian cancer, and breast cance…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
This clinical trial update describes ongoing specimen collection from participants with HIV infection, KSHV infection, and virus-related pre…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Natural History Study of Kaposi Sarcoma
The National Cancer Institute-sponsored natural history study of Kaposi sarcoma is currently recruiting. The study will observe disease prog…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Nirogacestat in Patients With Kaposi Sarcoma [Phase 2]
This document provides an update on a Phase 2 trial of nirogacestat for Kaposi sarcoma that is not yet recruiting.
-
EMA approval · 2026-04-16EMA Authorised: Zolsketil pegylated liposomal (doxorubicin hydrochloride, liposomal) — Accord Healthcare S.L.U.
The EMA authorised Zolsketil pegylated liposomal doxorubicin for ovarian cancer, Kaposi sarcoma, and multiple myeloma. The Marketing Authori…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Pomalidomide Treatment in Patients With Kaposi Sarcoma [Phase 2]
This is a Phase 2 clinical trial update for pomalidomide in patients with skin Kaposi sarcoma, sponsored by the National Cancer Institute; t…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV) [Phase 2]
Phase 2 clinical trial evaluating CYT107 (recombinant glycosylated human interleukin-7) for Kaposi sarcoma in people with HIV and immune non…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV [Phase 1]
Phase 1 study evaluating the combination of pomalidomide and nivolumab in people with virus-associated malignancies, including Kaposi sarcom…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Propranolol for the Treatment of Kaposi Sarcoma in Adults [Phase 2]
A Phase 2 clinical trial is evaluating propranolol for the treatment of Kaposi sarcoma in adults, sponsored by Washington University School …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Lenalidomide in Kaposi Disease Associated With HIV Infection [Phase 2]
This update notes the termination of a Phase 2 trial evaluating lenalidomide for Kaposi sarcoma associated with HIV infection.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma [Phase 1]
This clinical trial investigates pomalidomide in combination with liposomal doxorubicin for advanced or refractory Kaposi sarcoma. The Phase…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Preliminary Assessment of Safety and Tolerability of Dostarlimab in Combination Antiretroviral Therapy (cART) Refractory HIV Associated Kaposi Sarcoma [Phase 1]
Phase 1 trial evaluating the safety and tolerability of dostarlimab in combination with antiretroviral therapy for refractory HIV-associated…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma [Phase 1, Phase 2]
Clinical trial update for PDS01ADC as monotherapy and in combination with M7824 in advanced Kaposi sarcoma; Phase 1/2 trials are currently r…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium completed a study evaluating a screening tool to describe HIV-related cancer burden and patient characteristics, …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
This device feasibility trial, sponsored by Washington University School of Medicine, is evaluating precision imaging to assess Kaposi sarco…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV [Phase 1]
This is a Phase 1 clinical trial evaluating the combination of cabozantinib (XL184) and nivolumab in patients with various advanced cancers …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Precision Imaging to Evaluate Kaposi Sarcoma [NA]
Clinical trial update from Washington University School of Medicine evaluating precision imaging to assess Kaposi sarcoma; the study is not …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Trial of Ixazomib for Kaposi Sarcoma [Phase 2]
Phase 2 trial of ixazomib for Kaposi sarcoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
This ClinicalTrials.gov study from the National Cancer Institute aims to molecularly characterize tumors that are associated with viral infe…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Kaposi Sarcoma Chemotherapy and Research (KS-CARE)
This ClinicalTrials.gov entry notes an active but not recruiting study on Kaposi sarcoma in people with HIV, sponsored by UNC Lineberger Com…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection [Phase 2]
Phase 2 clinical trial results evaluating pomalidomide in HIV-positive patients with skin Kaposi sarcoma; results have been posted.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma [Phase 3]
This update describes a Phase 3 clinical trial evaluating paclitaxel in combination with pegylated liposomal doxorubicin for HIV-related Kap…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating abemaciclib for Kaposi sarcoma in HIV-associated and HIV-negative patients, curr…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Study of Propranolol to Treat Kaposi Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating propranolol for Kaposi sarcoma; the study is currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS withdrawal · 2026-01-22Clinical Trial Update: Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma [Phase 2]
Phase 2 trial of pembrolizumab plus lenvatinib for previously treated classic Kaposi sarcoma has been withdrawn.